Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-Masked Clinical Study Evaluating the Efficacy and Safety of RPh201 Treatment in Participants With Previous NAION

NCT03547206 is registered in ClinicalTrials.gov with Regenera Pharma Ltd as lead sponsor.

NCT NCT03547206
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03547206 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-Masked Clinical Study Evaluating the Efficacy and Safety of RPh201 Treatment in Participants With Previous NAION
Lead sponsor
Regenera Pharma Ltd
Phase
Phase 2
Overall status
Terminated
Start date
July 10, 2018
Completion date
September 27, 2020
Enrollment
165 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

nonarteritic anterior ischemic optic neuropathy